期刊文献+

P16蛋白在食管鳞癌及食管上皮不典型增生组织中的表达及意义 被引量:1

下载PDF
导出
摘要 目的探讨抑癌基因P16蛋白在食管鳞癌及食管上皮不典型增生组织中的表达及与临床病理特征间的关系。方法采用免疫组织化学方法检测60例食管鳞癌及30例不典型组织中P16蛋白的表达。结果P16蛋白在鳞癌中的阳性表达率为46.7%,P16蛋白表达缺失与鳞癌临床病理分期、淋巴结转移密切相关;在不典型增生组织中的阳性表达率为60%,Ⅲ级不典型增生中的表达率明显低于Ⅰ~Ⅱ级不典型增生。结论P16蛋白表达缺失与食管鳞癌的发生、发展密切相关。
出处 《齐齐哈尔医学院学报》 2009年第10期1169-1170,共2页 Journal of Qiqihar Medical University
  • 相关文献

参考文献6

  • 1Mathew R,Arora S,Khanna R,et al.Alterations in cyclin D1 expression in esophageal squamous cell carcinoma in the Indian population[J].J Cancer Res Clin Oncol,2001,127(4):251-257.
  • 2Arbiser JL.Molecular regulation of angiogenesis and tumorigenesis by signal transduction pathways:evidence of predictable and reproducible pattems of synergy in diverse neoplasms[J].Semin Cancer Biol,2004,14(2):81-91.
  • 3Rocco JW,Sidransky D.P16(MTS/CDKN2/NK4a) in cancer progressin[J].Exp Cell Res,2001,264(1):42-55.
  • 4Ohtani N,Yamakoshi K,Takashi A,et al.The P16NK4a-RB pathway:molecular link between cellular senescence and tumou suppression[J].J Med Invest,2004,51(34):146-153.
  • 5陈新,平育敏,白世祥,孟宪利,何明.p16和p53在食管鳞状细胞癌中的表达及意义[J].实用肿瘤杂志,2004,19(1):23-27. 被引量:15
  • 6马雪芹,丁艳丽.P16和PTEN蛋白在食管鳞癌组织中的表达及临床意义[J].青海医学院学报,2008,29(3):185-187. 被引量:3

二级参考文献19

  • 1邱镇,崔飞伦,许传亮,顾正勤,孙颖浩.联合PTEN和P27抑制前列腺癌侵袭和血管生成的实验研究[J].中华男科学杂志,2007,13(3):201-205. 被引量:6
  • 2[1]Viallard JF,Lacombe F,Belloc F, et al. Molecular mechanisms controlling the cell cycle:fundamental aspects and implications for oncology [J].Cancer Radiother, 2001,5(2):109-129.
  • 3[2]Sharpless NE, Bardeesy N, Lee KH, et al. Loss of pl6ink4a with retention of p16 Arf predisposes mice to tumorigenesis [J]. Nature, 2001,4(13):86-91.
  • 4[3]Soussi T. The p53 tumor suppressor gene: from mo-lecular biology to clinical investigation [J]. Ann NY Acad Sci, 2000,9(10):121-137.
  • 5[4]Hussain SP, Harris CC. p53 mutation spectrum and load: The generation of hypotheses linking the expose of endogenous or exogenous carcinogens to human cancer [J]. Mutation Res, 1999,4(28):23-31.
  • 6[5]Wadih A, Ryo N, Frank B, et al. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth [J]. Cancer Res, 1995,5(5):1351-1357.
  • 7[6]Zhou X, Tarmin I, Yin J, et al. The MTS1 gene is freqently mutated in squamouse cell carcinoma of the esophagus human esophageal tumors [J]. Oncogene, 1994,9(12):37-41.
  • 8[7]Liu Q, Yan YX, Mcclure M, et al. MTS1(CDKN2) tumor suppressor gene deletions are a frequent event in esophagus sqamous cancer and pancreatic adenocarcinoma cell lines [J]. Oncogene, 1995,10(3):619-625.
  • 9[8]Mori T, Miura K, Aoki T, et al. Frequent somatic mutation of the MTS1/CDK4(multiple tumor suppressor/cyclin-depen kinase-4 inhibitor) gene in esophageal squamous cell carcinoma [J]. Cancer Res, 1994,54(11):3396-.
  • 10[9]Osaki H, Kishi T, et al. Highly frequent homozygous deletion of the p16 gene in esophageal cancer lines [J]. Biochem Biophys Res Commun, 1994,203(2):1090-1098.

共引文献15

同被引文献7

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部